Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
BBIO Quote, Financials, Valuation and Earnings
Last price:
$76.56
Seasonality move
:
-6.92%
Day range:
$76.38 - $77.32
52-week range:
$27.23 - $78.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
41.22x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
2M
1-year change:
168.24%
Market cap:
$14.8B
Revenue:
$221.9M
EPS (TTM):
-$4.19
BBIO Analysts' Consensus Rating
The 16 analysts providing 12-month price projections for BridgeBio Pharma, Inc. shares anticipate an average target of $86.56, ranging from a low estimate of $65.00 to a high estimate of $110.00. This average target implies a growth of 12.28% compared to the current stock price of $76.56.
Consensus Price Target
$86.56
Highest Price Target
$110.00
Lowest Price Target
$65.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 11 | 14 | 15 |
| Hold | 3 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BBIO Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
